Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC

Clinical trial NCT06435013 · COMPLETED

Trial details

NCT number: NCT06435013
Sponsor: Sun Yat-sen University
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatocellular Carcinoma Lenvatinib

Start date: 2023-12-01
Primary completion: 2024-03-01
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.